Etomidate (ETO) Rapid Test Kit – Oral Fluid Screening

Key Features

• Detects Etomidate (ETO) in oral fluid
• Fast results in 5–10 minutes
• Easy, non-invasive sample collection
• High specificity and sensitivity
• Ideal for workplace, forensic, and clinical use

Intended Use

This test is intended for professional in vitro diagnostic use. It detects Etomidate in oral fluid samples at standard cut-off levels and provides preliminary screening results. For confirmation of positive outcomes, more specific analytical methods such as gas chromatography–mass spectrometry (GC/MS) should be used. Clinical discretion is advised in result interpretation.

Background

Etomidate is a short-acting intravenous anesthetic valued for its cardiovascular stability, frequently used in emergency procedures. However, its misuse has become a growing concern, particularly due to side effects like myoclonus and abuse-related incidents. As demand increases for fast, instrument-free testing methods, oral fluid screening offers a highly practical alternative to urine or blood analysis. The ETO Oral Fluid Test allows immediate detection with minimal handling or equipment.

Test Principle

The ETO Rapid Test operates on a competitive immunoassay principle. Etomidate, if present in the oral fluid specimen above the cut-off concentration, competes with an Etomidate–protein conjugate for limited antibody binding sites on the test line. A visible colored line will appear in the test region for negative samples. In contrast, the absence of a test line indicates a positive result. A control line confirms the proper function of the test.

Benefits

• Non-invasive sample collection
• Results in just 5–10 minutes
• Ideal for on-site drug screening
• No instrumentation required
• Easy-to-read results with built-in control line

Applications

• Law enforcement and forensic investigations
• Workplace drug testing
• Rehabilitation and addiction screening
• Clinical toxicology